Herbert Wertheim College of Engineering
Diabetes Tissue Engineering Laboratory
Led by Cherie Stabler · Biomedical Engineering
What we study
The lab develops biomaterials to protect and support pancreatic cells for diabetes treatment. They create 3D structures that guide cell growth and release therapeutic agents.
What working here is like
- Wet lab
- Papers
- 5
Recent papers, explained
- Advances in Cell Replacement Therapies for Diabetes
2025 · Diabetes
Reviews islet cell replacement therapies for type 1 diabetes treatment.
- Closing the Gap Between Vision and Victory in Type 1 Diabetes: The NIDDK Human Islet Research Network (HIRN) Initiative
2025 · Diabetes
Summarizes the NIDDK Human Islet Research Network's work on type 1 diabetes.
Show 3 more papersShow fewer
- Antioxidant Cerium Oxide Nanoparticle Coatings Impart Immunomodulatory Effects by Suppressing Antigen‐Specific Cytotoxic T Cell Activation
2025 · Journal of Biomedical Materials Research Part A
Shows cerium oxide nanoparticles suppress immune cell activation in hydrogels.
- Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead
2024 · Nature Reviews Endocrinology
- Encapsulated islet transplantation
2024 · Nature Reviews Bioengineering
Plain-language summaries are AI-written and reviewed by us; check the paper for details.
How to reach out
Cherie Stabler hasn't set up this page yet. You can also look them up in the UF directory (search “Cherie Stabler”).